US Trustee Wants Sorrento Ch. 11 Tossed Or Relocated

By Emily Lever · February 20, 2024, 8:24 PM EST

The U.S. Trustee's Office has moved to have Sorrento Therapeutics' Chapter 11 case dismissed, alleging the biopharmaceutical company manufactured a venue in Texas bankruptcy court, even as the debtor asked for...

To view the full article, register now.

Try a seven day FREE Trial

Already a subscriber? Click here to login

Documents

Case Information

Case Title

Sorrento Therapeutics, Inc.

Case Number

Court

Texas Southern

Nature of Suit

Date Filed

February 13, 2023

Recent Articles By Emily

April 25, 2024
Benefytt Successor Pursues Del.'s Bankruptcy Alternative
April 22, 2024
Petersen Health Shouldn't Get LLCs Back, Creditor Says
April 16, 2024
Bankrupt Breast Implant Co. Submits Ch. 11 Plan Disclosures
April 15, 2024
Humanigen Files Ch. 11 Plan Disclosures
April 04, 2024
Meet The Attys In Acorda Therapeutics' Ch. 11
February 15, 2024
Invitae Can Use Cash Collateral For Speedy Ch. 11
January 24, 2024
Latham Ducks Sanctions In Sorrento Ch. 11
January 23, 2024
Del. Judge Nixes Bidder Fees In Humanigen Ch. 11
January 17, 2024
Rite Aid Ch. 11 Stay Doesn't Apply To Execs, Investors Say
December 05, 2023
Ex-Hospital CFO, 3 Doctors Settle Kickback Case For $880K